| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022648 |
| Receipt No. | R000025905 |
| Official scientific title of the study | Effects of physical therapy intervention by the visual feedback using the Anti-Gravity-Treadmil treadmill of compression myelopathy postoperative give the walking disorder |
| Date of disclosure of the study information | 2016/06/20 |
| Last modified on | 2016/06/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effects of physical therapy intervention by the visual feedback using the Anti-Gravity-Treadmil treadmill of compression myelopathy postoperative give the walking disorder | |
| Title of the study (Brief title) | Effects of physical therapy intervention by the visual feedback using the Anti-Gravity-Treadmil treadmill of compression myelopathy postoperative give the walking disorder | |
| Region |
|
|
| Condition | |||
| Condition | Compression myelopathy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study is a prospective study involving physical therapy intervention, walking by using the Anti-Gravity Treadmill for Compression myelopathy patients are installed in our hospital, do the physical therapy intervention using visual feedback or research can contribute to the improvement of the capacity.
The walking ability improved early compression myelopathy patients by performing physical therapy interventions aimed, to obtain a demonstration of the effect early intervention, also it can be expected that there can be a new therapeutic means. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 10m walking test |
| Key secondary outcomes | Body sway inspection
Japan Orthopaedic Association score JOA Cervical Myelopathy Evaluation Questionnaire |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Intervention group the group to carry out the intervention by the visual feedback in addition to the normal physical therapy using the Anti-Gravity Treadmill, and a control group to a group to implement only the normal physical therapy. | ||
| Interventions/Control_2 | The intervention group, Anti-Gravity Treadmillsettings at 20% relieving, carried out for 5 minutes at optimal walking speed (0.2 ~ 4.0km / h).
Anti-Gravity Treadmill in use using a video camera, is carried out while projected to monitor the gait of the patient's own. Intervention period shall be three weeks after surgery from Anti-Gravity Treadmill available time (post-operative average length of stay in our hospital). |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All cases in which surgery was performed treatment in the hospital than the preoperative diagnosis of compression myelopathy | |||
| Key exclusion criteria | 1)Patients with pre-operative complications of cerebral vascular disorders
2)Patient dementia 3)Patient it is difficult to follow the inspection enforcement's instructions 4)Principal investigator or sharing deems unsuitable as a subject |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihiko Taguchi |
| Organization | National University Corporation Yamaguchi University Hospital length |
| Division name | Graduate School of Medicine orthopedics |
| Address | 1-1-1, Minamikogushi, Ube-shi, Yamaguchi, 755-8505, Japan |
| TEL | 0836-22-2266 |
| wa.n08fk@gmail.com | |
| Public contact | |
| Name of contact person | Makoto Agari |
| Organization | National University Corporation Yamaguchi University Hospital |
| Division name | Rehabilitation department |
| Address | 1-1-1, Minamikogushi, Ube-shi, Yamaguchi, 755-8505, Japan |
| TEL | 0836-22-2651 |
| Homepage URL | |
| wa.n08fk@gmail.com | |
| Sponsor | |
| Institute | National University Corporation Yamaguchi University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | National University Corporation Yamaguchi University Hospital
Graduate School of Medicine orthopedics |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025905 |